We provide you with 20 years of free, institutional-grade data for GLSI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GLSI. Explore the full financial landscape of GLSI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Greenwich LifeSciences, Inc(NASDAQ:GLSI) 
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other human epidermal growth factor receptor 2/neu-expressing (HER2/neu) cancers. Its lead product candidate is the GP2, an immunotherapy, which ...
Website: http://www.greenwichlifesciences.com
Founded: 2006
CEO: Snehal Patel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about GLSI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.